Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CREB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
UBTF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928162 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
KLHL20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAMA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ISG20L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VIPR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZCRB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSTM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP6V0E1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPATCH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DAOA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAV1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMCO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on